PIRAZINAMIDA ATB 500mg tablets medication leaflet

J04AK01 pyrazinamide • Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Other drugs for treatment of tuberculosis

Pyrazinamide is an antitubercular medication used in the treatment of tuberculosis, particularly in the initial phase of combination therapy. It works by inhibiting the synthesis of fatty acids essential for Mycobacterium tuberculosis, contributing to bacterial destruction.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor liver function.

Patients should be aware of potential side effects, such as nausea, joint pain, or symptoms of liver damage. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, joint pain, and elevated liver enzymes. In rare cases, severe reactions such as hepatitis or allergic reactions may occur. Patients should be informed of these risks before use.

General data about PIRAZINAMIDA ATB 500mg

Substance: pyrazinamide

Date of last drug list: 01-06-2025

Commercial code: W60213002

Concentration: 500mg

Pharmaceutical form: tablets

Quantity: 1500

Product type: generic

Price: 1018.36 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ANTIBIOTICE S.A. - ROMANIA

Holder: ANTIBIOTICE S.A. - ROMANIA

Number: 5749/2013/02

Shelf life: 3 years

Other substances similar to pyrazinamide

Compensation lists for PIRAZINAMIDA ATB 500mg ANTIBIOTICE

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

1018.36 RON

1018.36 RON

0.00 RON

NHP 1.B (C2) - Tuberculosis

Price

Copayment

Patient

1018.36 RON

1018.36 RON

0.00 RON